SUPREMO

BIG 2-04

Partager cette publication

Selective Use of Postoperative Radiotherapy AftEr Mastectomy: adjuvant chest wall irradiation for ‘intermediate risk’ breast cancer following mastectomy.

Funding: UK Medical Research Council, EORTC, Cancer Australia, William and Elizabeth Davies Charitable Trust, Peter Chan Jee Yat Foundation, Yeung Ying Yin and May Yeung Foundation

NCT00966888

To lean more, visit also https://www.supremo-trial.com/ 

More To Explore

PANACEA

Panacea BIG 4-13 PANACEA stands for anti-PD-1 monoclonAl aNtibody in AdvanCed, trastuzumab-resistant, HER2-positive breAst cancer. A phase Ib/II trial evaluating the efficacy of pembrolizumab and trastuzumab

Read More

DECRESCENDO

DECRESCENDO BIG 19-02 De-Escalation of adjuvant ChemotheRapy in HER2-positive, EStrogen reCEptor-negative, Node-negative early breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy and Dual HER2 blOckade Share

Read More